A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
2014 ◽
Vol 16
(2)
◽
pp. 63-71
◽
2018 ◽
Vol 21
(12)
◽
pp. 1197-1203
◽
Keyword(s):
2016 ◽
Vol 18
(12)
◽
pp. 1207-1216
◽
2018 ◽
Vol 22
(1)
◽
pp. 41
◽
Keyword(s):
1992 ◽
Vol 9
(10)
◽
pp. 908-914
◽
2018 ◽
Vol 10
(1)
◽
pp. 37-50
◽
Keyword(s):